These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins. Khan F; Brady S; Kuttikat A Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115 [TBL] [Abstract][Full Text] [Related]
6. Immune-mediated necrotising myopathy: a rare cause of hyperCKaemia. Liang E; Rastegar M BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29691272 [TBL] [Abstract][Full Text] [Related]
7. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830 [TBL] [Abstract][Full Text] [Related]
8. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy. Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419 [TBL] [Abstract][Full Text] [Related]
9. Unveiling the Rare Complication: Statin-Induced Immune-Mediated Necrotizing Myopathy. Chowdhury FH; Mahneva O; Maharaj M; Marciales W Am J Case Rep; 2023 Dec; 24():e941387. PubMed ID: 38087774 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database. Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756 [TBL] [Abstract][Full Text] [Related]
12. Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy. Adler B; Christopher-Stine L; Tiniakou E BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606030 [TBL] [Abstract][Full Text] [Related]
13. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series. Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470 [TBL] [Abstract][Full Text] [Related]
14. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data. Rademacher JG; Glaubitz S; Zechel S; Oettler M; Tampe B; Schmidt J; Korsten P Clin Exp Rheumatol; 2022 Feb; 40(2):320-328. PubMed ID: 35225222 [TBL] [Abstract][Full Text] [Related]
16. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy. Nichols L; Pfeifer K; Mammen AL; Shahnoor N; Konersman CG J Gen Intern Med; 2015 Dec; 30(12):1879-83. PubMed ID: 25855481 [TBL] [Abstract][Full Text] [Related]
17. Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders. Woolley M; Stebbings S; Highton J Intern Med J; 2018 Jan; 48(1):32-36. PubMed ID: 28782163 [TBL] [Abstract][Full Text] [Related]
18. Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases. Nazir S; Lohani S; Tachamo N; Poudel D; Donato A J Clin Rheumatol; 2017 Apr; 23(3):149-154. PubMed ID: 28277343 [TBL] [Abstract][Full Text] [Related]